Entera Bio annual revenue
2018
2019
2020
2021
2022
2023
2024
2025
Entera Bio Revenue Growth & History (ENTX)
Entera Bio reported $42,000 in revenue for fiscal 2025, a decrease of 76.80% from the previous fiscal year.
View full Entera Bio company overviewEntera Bio annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $42,000 | −$139,000 | −76.80% |
| 2024 | 2024-12-31 | $181,000 | $181,000 | — |
| 2023 | 2023-12-31 | $0 | −$134,000 | −100.00% |
| 2022 | 2022-12-31 | $134,000 | −$437,000 | −76.53% |
| 2021 | 2021-12-31 | $571,000 | $206,000 | +56.44% |
| 2020 | 2020-12-31 | $365,000 | $129,000 | +54.66% |
| 2019 | 2019-12-31 | $236,000 | −$264,000 | −52.80% |
| 2018 | 2018-12-31 | $500,000 | — | — |
Entera Bio quarterly revenue
Q2.19
Q2.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $0 | $0 | — |
| Q1 2026 | 2026-03-31 | $0 | −$42,000 | −100.00% |
| Q4 2025 | 2025-12-31 | $0 | −$82,000 | −100.00% |
| Q3 2025 | 2025-09-30 | $0 | −$42,000 | −100.00% |
| Q2 2025 | 2025-06-30 | $0 | −$57,000 | −100.00% |
| Q1 2025 | 2025-03-31 | $42,000 | $42,000 | — |
| Q4 2024 | 2024-12-31 | $82,000 | $82,000 | — |
| Q3 2024 | 2024-09-30 | $42,000 | $42,000 | — |
| Q2 2024 | 2024-06-30 | $57,000 | $57,000 | — |
| Q1 2024 | 2024-03-31 | $0 | $0 | — |
| Q4 2023 | 2023-12-31 | $0 | −$14,000 | −100.00% |
| Q3 2023 | 2023-09-30 | $0 | −$8,000 | −100.00% |
| Q2 2023 | 2023-06-30 | $0 | −$44,000 | −100.00% |
| Q1 2023 | 2023-03-31 | $0 | −$68,000 | −100.00% |
| Q4 2022 | 2022-12-31 | $14,000 | −$151,000 | −91.52% |
| Q3 2022 | 2022-09-30 | $8,000 | −$132,000 | −94.29% |
| Q2 2022 | 2022-06-30 | $44,000 | −$65,000 | −59.63% |
| Q1 2022 | 2022-03-31 | $68,000 | −$89,000 | −56.69% |
| Q4 2021 | 2021-12-31 | $165,000 | — | — |
| Q3 2021 | 2021-09-30 | $140,000 | — | — |
| Q2 2021 | 2021-06-30 | $109,000 | $57,000 | +109.62% |
| Q1 2021 | 2021-03-31 | $157,000 | — | — |
| Q2 2020 | 2020-06-30 | $52,000 | −$22,000 | −29.73% |
| Q2 2019 | 2019-06-30 | $74,000 | — | — |
Entera Bio revenue growth trends
Over the last five reported fiscal years, revenue declined from $365,000 to $42,000, a compound annual decline of 35.11%. Entera Bio's latest reported quarter, Q2 2026, generated $0 in revenue.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Entera Bio source filings ↗